Skip to content

formoline L112 EXTRA

by Certmedica International GmbH EUDAMED

Withdrawn Not intended for the EU market

Ref 14-750-16-04

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberG70 109587 0002 Date27 Jul 2026IssuedStatusWithdrawn Not intended for the EU market expires 7 Oct 2031

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Withdrawn

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • G70 109587 0002 Reissued

    Technical documentation EU MDR

    Notified body
    TÜV SÜD Product Service GmbH 0123
    Issued
    27 Jul 2026
    Expires
    7 Oct 2031
    Valid from
    8 Oct 2026

Specification

EUDAMED

Device Name
L112-Produktreihe
Model / Reference
14-750-16-04
Primary DI / UDI-DI
04260103335386, 04260103335300
Basic UDI-DI
426010333L112T4
EMDN Code
G030699 Devices for the non-surgical treatment of obesity - other
Device Class
Class III
Market of Registration
Finland

Manufacturer details

EUDAMED SRN
DE-MF-000006199

Other devices from Certmedica International GmbH

See all devices from Certmedica International GmbH →

Properties

  • Animal Tissues

Other properties (12)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No